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Introduction 
The increasing integration of health care delivery systems provides an 
opportunity to manage entire episodes of care in a patient-focused manner and 
to assess the impact of care on patient outcomes, including patient-reported 
outcomes (PROs).1 The National Institutes of Health (NIH) PROMIS initiative 
(for Patient Reported Outcomes Measurement Information System) describes 
PROs as direct feedback from patients “on their feelings or what they are able 
to do as they are dealing with chronic diseases or conditions.” They reflect the 
health status or health-related quality of life circumstances of patients (broadly 
defined). Such information is reported by individuals themselves or, in some 
cases, by proxy respondents such as parents for young children or close 
relatives of persons unable to report for themselves. 
PRO information is widely gathered in clinical and health services research; 
it is increasingly collected and used in clinical practice settings as well.2–7 PROs 
are relevant for many activities: helping patients and their clinicians make 
informed decisions about health care, monitoring the progress of care, setting 
policies for coverage and reimbursement of health services, improving the 
quality of health care services, and tracking or reporting on the performance of 
health care delivery organizations. 
These last two activities are gaining increasing attention in the US health 
care system. The nation is engaging in more efforts to expand health care 
coverage to many millions of citizens through the Patient Protection and 
Affordable Care Act (ACA). Many organizations are working to ensure higher 
value of health care through enhanced attention to measuring and improving 
quality of care and patient outcomes.8 For example, the Patient-Centered 
Outcomes Research Institute (PCORI), established by the ACA, is actively 
pursuing ways to increase the use of PROs for clinical care, research, and 
performance assessment.
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The National Quality Forum Project
The National Quality Forum (NQF), a national organization that has been 
deeply involved in moving the quality-improvement agenda forward for many 
years (http://www.qualityforum.org), endorses and promulgates quality-of-
care and performance measures that various provider groups, regulatory 
agencies, payers and insurers, and others can use for accountability and quality 
improvement activities. In 2012 and 2013, the organization began an initiative 
to find PROs that might be added to its extensive collection of performance 
measures. Its National Voluntary Consensus Standards for Patient Outcomes: A 
Consensus Report defined outcomes as being important because they “reflect 
the reason that an individual seeks healthcare services.”1 The individual 
patient’s voice in many performance measures, however, has largely been 
missing. Few ways to assess performance are available at the organizational 
level, even though patients are often the best able to report on the experiences 
and results of their individual care. 
To fill that gap, NQF convened an expert panel at two public meetings 
and, as background for its deliberations, commissioned two authoritative 
background papers. This monograph is a revised and updated version of 
the first of these two papers, which provided the background on issues 
about selecting PROs for use in a variety of applications pertinent to the 
NQF mission and activities. The second paper, Patient-Reported Outcomes 
in Performance Measurement,9 dealt with issues relating to processes for 
endorsing performance measures that reflect the end results (ultimate 
outcomes) of health care. Its primary focus was on accountable health care 
organizations.
This monograph applies the conceptual and organizational frameworks that 
NQF has pioneered in the past decade or so. NQF distinguishes PROs, patient-
reported outcome measures (or PROMs), and patient-reported outcome 
performance measures (or PRO-PMs). NQF endorses PRO-PMs through 
transparent and consensus-based procedures. This monograph addresses the 
PROs that are likely to be used to inform PRO measures (PROMs) that would 
underpin scientifically acceptable and feasible performance measures. We do 
not address issues with identifying, evaluating, or endorsing PRO-PMs for 
health care organizations or clinicians.
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To accomplish our assigned objective, we completed a comprehensive 
review of the published peer-reviewed literature as well as published 
documents (e.g., book chapters, position statements; guidance from the 
US Food and Drug Administration10) about standard measurement theory. 
Based on our findings in the published literature, we created a comprehensive 
annotated outline reflecting the methodological considerations most important 
to address. We then revised it in consultation with representatives from NQF to 
ensure that the paper accomplished the NQF’s high-priority objectives. 
Following the initial drafting of the manuscript, our group of authors at 
Northwestern University worked in conjunction with Kathleen Lohr, RTI 
International, who comprehensively reviewed and revised the manuscript 
draft. We submitted the revised manuscript draft for review and comment at 
the NQF Patient Reported Outcomes Workshop 1 in July 2012. A final version 
of the manuscript, which incorporated revisions based on feedback from the 
workshop, was submitted to NQF in September 2012. That manuscript includes 
numerous authoritative citations to research from this field up through that 
date. Dr. Lohr and the other authors revised the manuscript further to meet the 
requirements of an RTI Press monograph and to update some of the citations; 
the result is this monograph.  
Concepts and Definitions
PROs are defined here as any report of the status of a patient’s health condition, 
health behavior, or experience with health care that comes directly from the 
patient, without interpretation of the patient’s response by a clinician or anyone 
else (Table 1). There are many available PRO measurement tools, which we 
refer to here as patient-reported outcome measures, or PROMs. By using 
direct, unfiltered inquiry, PROMs measure what patients are able to do and 
how they feel. They reflect the direct voice of the patient, as perceived by the 
patient.
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Table 1. Definitions and key concepts for patient-reported outcomes and 
measures
Key Concept Definition
Patient A person who is receiving health care services or using long-term health 
care support services.
Patient-
reported 
outcome (PRO)
Any information on the outcomes of health care obtained directly 
from patients without modification by clinicians or other health care 
professionals. For purposes of this monograph, we use this term broadly 
to include any patient input, whether or not it is standardized or gathered 
with a structured questionnaire.
Patient-
reported 
outcome 
measure 
(PROM)
Any standardized or structured questionnaire regarding the status of a 
patient’s health condition, health behavior, or experience with health care 
that comes directly from the patient (i.e., a PRO). The use of a structured, 
standardized tool such as a PROM will yield quantitative data that enables 
comparison of patient groups or providers. One example of a PROM is the 
nine-item Patient Health Questionnaire (PHQ-9).
Performance 
measure
Numeric quantification of health care quality for a designated 
accountable health care entity, such as a hospital, health plan, nursing 
home, clinician, etc.
PRO-based 
performance 
measure 
(PRO-PM)
A performance measure that is based on patient-reported outcomes 
assessed through data often collected through a PROM and then 
aggregated for an accountable health care entity. One example is the 
percentage of patients in an accountable care organization with an 
improved depression score as measured by a standardized tool such as 
the PHQ-9.
e-health Health-related Internet applications that deliver a range of content, 
connectivity, and clinical care. Examples include online formularies, 
prescription refills, test results, physician-patient communication.11,12
Patient-
centered 
outcomes 
research 
(PCOR)
Integration of patient perspectives and experiences with clinical and 
biological data collected from the patient to evaluate the safety and 
efficacy of an intervention (www.pcori.org).
Reliability The extent to which a scale or measure yields reproducible and 
consistent results.13 Reliability of data elements refers to repeatability and 
reproducibility of the data elements for the same population in the same 
time period. Reliability of the measure score refers to the proportion of 
variation in the performance scores attributable to systematic differences 
across the measured entities (or signal) in relation to random error (or 
noise).
Validity The extent to which an instrument measures what it is intended 
to measure and can be useful for its intended purpose.13 Validity of 
instruments can be assessed in numerous ways, often in comparison with 
an authoritative source (such as a similar validated instrument). Validity 
of measure scores can refer to the correctness of conclusions that users 
might draw from a reliable and valid instrument (as, for instance, that a 
better score on a quality measure reflects higher quality of health care).
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Using Patient-Reported Outcome Measures (PROMs)
A large literature supports the use of PROMs and provides cogent evidence 
suggesting that clinicians are limited in accurately estimating outcomes for 
patients.14–18 PROMs enable clinicians, patients and families, and others to 
assess patient-reported health status domains (e.g., health status; physical, 
mental, and social functioning; health behavior; experience with health care). 
A wide variety of patient-level instruments to measure PROMs have been 
used for clinical research purposes and to guide clinical care. Many have been 
evaluated and catalogued by the NIH PROMIS network and made available 
through the PROMIS Assessment Center (www.nihpromis.org/software/
assessmentcenter).
Two major challenges to using PROMs for purposes of accountability and 
performance improvement must be addressed. First, they have not yet been 
widely adopted in clinical use; thus, they are unfamiliar to many health care 
professionals, payers, and others in health care systems. Second, little is known 
about the best set of responsive questions to aggregate for the purpose of 
measuring performance of the health care organizations and systems. 
Many in the health sector are showing increasing interest in moving toward 
use of PROMs for these clinical, quality improvement, and accountability 
applications. Foundational work still needs to address methodological and 
data challenges. Efforts in the early 2010s focused on developing and testing 
mechanisms for collecting patient-reported data. A crucial element of this is 
considering methodological issues in some depth. Among the more difficult 
problems are collecting PRO data in the clinical environment and aggregating 
data to assess organization- and clinician-level performance.
In the remainder of this monograph, we address the major methodological 
issues related to the selection, administration, and use of PROMs for individual 
patients in clinical practice settings. We highlight best practices in identifying 
and using PROMs in performance measures. Given such information, those 
concerned with identifying and choosing appropriate PROMs as candidate 
measures for use in performance assessment and related applications can move 
ahead in this arena. 
 
Types of Patient-Reported Outcomes 
PROMs can be used to assess a wide variety of health-relevant concepts. 
Of particular salience for quality and performance measurement efforts are 
the following five categories: health-related quality of life, functional status, 
symptoms and symptom burden, health behaviors, and the patient’s health care 
experience. These concepts are neither mutually exclusive nor exhaustive. 
Table 2 summarizes the main characteristics of these types of PROMs. 
In the table, we highlight only key advantages or drawbacks for each PRO 
category. In the subsections that follow, we focus on core components or 
attributes of the specific category in question of particular relevance for 
measurement (including efficient performance measurement). Consequently, 
the information for any given PRO category may differ from that for other 
categories. 
Table 2. Main characteristics of patient-reported outcomes
PRO Category Main Characteristics Main Strengths Main Limitations
Health-related 
quality of life 
(HRQL)
• Is multidimensional
• Can be generic or 
condition-specific
• Yields a global 
summary of well-
being
• May not be 
considered a 
sufficiently specific 
construct
Functional 
status
• Reflects ability to 
perform specific 
activities
• Can be used 
in addition to 
performance-
based measures of 
function
• May reflect 
variations in self-
reported capability 
and actual 
performance of 
activities
Symptoms 
and symptom 
burden
• Are specific to type 
of symptom of 
interest
• May identify 
symptoms not 
otherwise captured 
by medical workup
• Are best assessed 
through self-report
• May fail to capture 
general, global 
aspects of well-
being considered 
important to 
patients
(continued)
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Health-Related Quality of Life
One class of PRO measures health-related quality of life (HRQL). HRQL is a 
multidimensional19 construct encompassing physical, social, and emotional 
well-being associated with illness and its treatment.20 Different types of HRQL 
measures21,22 are useful for different purposes.23 Numerous generic health status 
measures, such as the Medical Outcomes Study Short Form SF-36 (and related 
measures) and the Sickness Impact Profile are classic examples.24–27 This type 
of PROM is useful in assessing individuals both with and without a health 
condition. Such data allow researchers, clinicians, and others to compare 
groups with and without a specific condition and to estimate population 
norms. 
A health utility or preference measure is also not disease-specific. It 
provides a score ranging from 0 (death) to 1 (perfect health) that represents the 
value that a patient places on his or her own health.28 Experts can use scores 
from these types of measures to calculate quality-adjusted life years or compare 
information to population norms. 
Table 2. Main characteristics of patient-reported outcomes
PRO Category Main Characteristics Main Strengths Main Limitations
Health 
behaviors
• Are specific to type 
of behavior
• Typically measure 
frequency of 
behavior
• Target specific 
behavior categories
• Validity may be 
affected by social 
desirability
• May produce 
potential patient 
discomfort in 
reporting socially 
undesirable 
behaviors
Patient 
experience
• Concerns 
satisfaction 
with health care 
delivery, treatment 
recommendations, 
and medications (or 
other therapies)
• Reflects actual 
experiences with 
health care services
• Fosters patient 
activation
• Is an essential 
component of 
patient-centered 
care
• Is valued by 
patients, families, 
and policy makers
• Relates to treatment 
adherence
• Relates to health 
behaviors and 
health outcomes
• May be a complex, 
multidimensional 
construct
• Requires 
confidentiality to 
ensure patient 
comfort in 
disclosing negative 
experiences
• Does not provide 
sufficient evidence 
that activation 
enhances health 
care decision 
making
(continued)
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Many PROMs are intended for use in populations with chronic illnesses.29–31 
Over the past 8 years, the PROMIS network has developed a considerable 
number of PROMs in physical, mental, and social health for adults and infants, 
children, and adolescents with chronic conditions.32,33 Neuro-QOL is another 
measurement effort focused on capturing important areas of functioning and 
well-being in neurologic diseases.34 These measurement efforts do not reference 
a specific disease in the items; thus, they permit comparisons across conditions. 
Other PROMs are targeted on a specific disease (e.g., spinal cord injury) 
or treatment (e.g., chemotherapy).35,36 Often these instruments are developed 
so that investigators can demonstrate responsiveness to treatment in a clinical 
trial rather than compare data against population norms or information 
on other conditions.37 Condition-specific PROMs often provide additional, 
complementary information about a patient’s HRQL.30,38–40
Functional Status
Another type of PROM is a functional status measure. Functional status refers 
to a patient’s ability to perform both basic and more advanced (instrumental) 
activities of daily life.41 Examples of functional status include physical function, 
cognitive function, and sexual function. As with HRQL instruments, a 
large number of functional status measures exist, but they vary widely in 
quality.42 Some may address a very specific type of function (e.g., Upper Limb 
Functional Index) or be developed for use in a specific disease population (e.g., 
patients with multiple sclerosis), whereas others may be appropriate for use 
across chronic conditions.43–49
Symptoms and Symptom Burden
Symptoms such as fatigue and pain intensity are key domains for PROMs. 
Symptoms are typically negative, and their presence and intensity are best 
assessed through patient report.50 Scales characterize the severity of the 
symptoms. The impact of symptoms, such as the degree to which pain 
interferes with usual functioning, is also a common focus of PROMs. Symptom 
burden captures the combination of both symptom severity and impact 
experienced with a specific disease or treatment.50 
Common symptom and symptom burden measures include the Functional 
Assessment of Chronic Illness Therapy—Fatigue scale, which is not targeted 
on any one condition. By contrast, disease-focused symptom indexes include 
the symptom indexes for various cancer types set out by the National 
Comprehensive Cancer Network and a dyspnea-specific instrument for 
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chronic obstructive pulmonary disease.51,52 PROMIS investigators developed 
the PROMIS Pain Interference measure, which quantifies the impact of pain on 
functioning.53
Health Behaviors
Yet another category of PROMs assesses health behaviors. Although health 
behaviors may be considered predictors of health outcomes, they are also 
health outcomes in their own right in the sense that health care interventions 
can have an impact on them. Information from health behavior PROMs serves 
several important clinical purposes. Clinicians can use it to monitor risk 
behaviors with potentially deleterious health consequences. This information 
enables practitioners to identify areas for risk reduction and health promotion 
interventions among their patients. Health behavior PROMs can also be used 
to assess patients’ response to health promotion interventions and to monitor 
health behaviors over time. 
Health risk assessments (HRAs) illustrate how health behavior PROMs 
can be incorporated into health promotion and disease prevention programs. 
Defined by the US Centers for Disease Control and Prevention (CDC) as 
tools to measure individual health, HRAs may consist of clinical examination 
or laboratory test results as well as health behavior PROMs.54 A recent 
report from the US Agency for Healthcare Research and Quality (AHRQ) 
identified three key components in the process of implementing HRAs in 
health promotion: (1) patient self-reported information to identify risk factors 
for disease, (2) individualized health-specific feedback to patients based 
upon the information they reported, and (3) at least one health promotion 
recommendation or intervention.55
Although HRAs have been implemented in community settings, 
universities, and health maintenance organizations, they have been most 
commonly implemented in workplace settings.55 An extensive review of 
HRA program outcomes concluded that, in many cases, implementing HRA 
programs improved health behaviors and intermediate health outcomes (e.g., 
blood pressure); however, the evidence did not demonstrate whether using 
HRAs affected disease incidence or health outcomes over the medium to long 
term.55
As the emphasis on the importance of health behaviors has increased, 
so has the number of available PROs developed to assess health behaviors 
across multiple domains. Health behavior PROs may assess general health 
by measuring risk factors without a focus on a specific disease or behavioral 
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category. Two examples of health behavior PROMs measuring multiple risk 
factors that the National Committee for Quality Assurance has certified are the 
Personal Wellness Profile56 and the Insight Health Risk Appraisal Survey.57
In addition, several large-scale health behavior assessment systems 
provide additional context for the use of general health behavior PROMs. The 
Behavioral Risk Factor Surveillance System (BRFSS), created in 1984 by the 
CDC as a state-based system, uses a standardized questionnaire to measure 
health risk and health promotion behaviors. These include health awareness, 
tobacco use, consumption of fruits and vegetables, physical activity, seatbelt 
use, immunization, and alcohol consumption.58 The National Health and 
Nutrition Examination Survey (NHANES) constitutes another large-scale 
implementation of health behavior PROMs. Established by the CDC in the 
1960s, NHANES includes health behavior surveys in addition to clinical 
examinations to assess health status at the population level.59 
The health behavior survey portion of NHANES assesses a wide range of 
health risk and health promotion behaviors, including smoking, drug use, 
alcohol use, sexual practices, physical activity, dietary intake, and reproductive 
health practices.59 Health behavior PROMs can also assess risk factors 
associated with specific diseases (e.g., smoking) or those related to specific 
behavioral categories (e.g., physical activity, seatbelt use, food consumption). 
The health risk survey, an interactive computer-based survey assessing alcohol 
consumption and smoking,60 is one example. Another is the CAGE-Adapted to 
Include Drugs (CAGE-AID) questionnaire, a self-reported screening measure 
of substance use disorder among treatment-seeking adolescents. Its name 
derives from its four main questions (Cutting down, being Annoyed if people 
criticize drinking, feeling Guilty about drinking, and needing an Eye-opener).61
A subset of health behavior PROMs assesses health-promoting behaviors. 
Examples of such PROM instruments include “Starting the conversation,” 
a brief measure of dietary intake;62 “Exercise as the fifth vital sign,” a brief 
measure of physical activity;63 School Health Action, Planning and Evaluation 
System (SHAPES), a school-based self-report physical activity measure;64 and 
the Morisky Medication Adherence Scale (8-item).65
Patient Experience of Care
Patient ratings of health care are an integral component of patient-centered 
care. In its definition of the essential dimensions of patient-centered care, the 
Institute of Medicine (now known as the National Academy of Medicine) 
includes shared decision making among clinicians, patients, and families; self-
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efficacy and self-management skills for patients; and the patient’s experience 
of care.66,67 Measurement of patient ratings is a complex concept that is related 
to perceived needs, expectations of care, and experience of care.68–75 Patient 
ratings can cover the spectrum of patient engagement, from experience to 
shared decision making to self-management to full activation. 
Clinicians’ recognition of patient preferences and values can help health 
care professionals tailor treatments based on informed decisions that their 
patients might make based on those preferences. In fact, improving decision 
quality is one critically important step that the nation can take to improve the 
quality (processes and outcomes) of health care and thus enhance value for 
health care expenditures. For this reason, patients’ ratings of their experiences 
with care not only provide information very salient to patients and families, 
but they also have considerable policy implications. Each safe practice in the 
updated NQF consensus report includes a section titled “Opportunities for 
Patient and Family Involvement.”76
The three major types of patient health care ratings relate to evaluations of 
patient satisfaction, patient motivation and activation, and patient reports of 
their actual experiences. Patient satisfaction is a multidimensional construct 
that includes patient concerns about the disease and its treatment, issues of 
treatment affordability and financial burden for the patient, communication 
with health care providers, access to services, satisfaction with treatment 
explanations, and confidence in the physician.77–83 Shikiar and Rentz proposed 
a three-level hierarchy of satisfaction: (1) satisfaction with health care delivery, 
including issues of accessibility, clinician-patient communication, and quality 
of facilities; (2) satisfaction with the treatment regimen, including medication, 
dietary and exercise recommendations, and similar elements of therapies; and 
(3) satisfaction with the medication itself, rather than the broader treatment.73 
Patient satisfaction has important implications for clinical decision making 
and enhancing the delivery of health care services; it is increasingly the focus 
of research and evaluation of medical treatments, services, and interventions.84 
It is an important indicator of future adherence to treatment.72,85–90 Satisfaction 
has a long history of measurement, and numerous instruments are 
available.70,75,91–99 
One potentially important predictor of health outcomes is patient 
activation, or the degree to which patients are motivated and have the relevant 
knowledge, skills, and confidence to make optimal health care decisions.100-102 
Hibbard and colleagues102 developed a 13-item scale, the Patient Activation 
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Measure (PAM),103,104 which demonstrated favorable psychometric properties 
in several cross-sectional and some longitudinal studies.101 Although 
appreciation of the benefits of activated patients is increasing,105 commensurate 
support is lacking to help patients become more activated with respect to 
their health care decision making.104 Although research supports the claim 
that improvements in patient activation are associated with improvements in 
self-reported health behaviors,101,105 additional research is necessary to better 
understand both these relationships and their relevance to actual behavior. 
Patient activation, as measured by the PAM or otherwise, may be a useful 
moderator or mediator of PROs that will in turn contribute to performance 
measurement.
An important contemporary focus is on measuring patient reports of 
their actual experiences with health care services.106 Reports about care are 
often regarded as more specific, actionable, understandable, and objective 
than general ratings alone.107,108 The Consumer Assessment of Healthcare 
Providers and Systems (CAHPS) program is a multiyear AHRQ initiative to 
support and promote the assessment of consumers’ experiences with health 
care. The CAHPS program has two main goals: (1) to develop standardized 
patient questionnaires and (2) to generate tools and resources that produce 
understandable and usable comparative information for both consumers and 
health care providers. The CAHPS project has become a leading mechanism 
for the measurement of patient perspectives on health care access and quality.
Method and Mode of Administration, Data Collection, 
and Analysis 
To accommodate the needs of patients with diverse linguistic, cultural, 
educational, and functional skills, clinicians and researchers require some 
flexibility in choosing appropriate methods and modes of questionnaire 
administration for PROMs.109 Numerous issues complicate scoring and 
analyzing PROM response data. We first describe these methods issues 
(Table 3)—sources of reports, modes of administration, methods of 
administration, settings, and scoring—and then discuss barriers. 
As with the earlier descriptions of core PRO categories such as health-
related quality of life, we highlight in this section the critical issues for 
measurement methods—i.e., the advantages or drawbacks that users 
would most need to take into account. This information reflects standard 
measurement theory (classical or contemporary) and is based on decades of 
published research and theoretical papers and inputs from experts involved 
with projects such as PROMIS.
Table 3. PRO methods: characteristics, strengths, and limitations
Methodological 
Issue
Main Characteristics Main Strengths Main Limitations
Source of report
Self Person responds 
about himself or 
herself
• Expert on own 
experience
• Not always possible 
to assess directly, 
e.g., because 
of cognitive or 
communication 
deficits or age/
developmental level
Proxy Person responds 
about someone else
• Useful when target 
of assessment is 
unable to respond
• Can provide 
complementary 
information
• May not accurately 
represent subjective 
or other experiences
(continued)
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Table 3. PRO methods: characteristics, strengths, and limitations
Methodological 
Issue
Main Characteristics Main Strengths Main Limitations
Mode of administration
Self Person self-
administers PROM 
and records the 
responses
• Cost-effective
• May yield more 
participant 
disclosure
• Proceed at one’s 
own pace
• Potential for missing 
data
• Simple survey 
design (e.g., minimal 
skip patterns)
Interviewer Interviewer reads 
questions aloud and 
records the responses
• More complex 
survey design (e.g., 
skip patterns)
• Useful for 
respondents with 
reading, writing, or 
vision difficulties
• Interviewer costs
• Potential for bias 
(interviewer bias, 
social desirability 
bias, acquiescent 
response sets)
Method of administration
Paper-and-pencil Patient self-
administers PROM 
using paper and a 
writing utensil
• Cost-effective • Prone to data entry 
errors
• Data entry, scoring 
require more time
• Less amenable to 
incorporation within 
EHR
Electronic Patient self-
administers PROM 
using computer- or 
telephone-based 
platform
• Interactive
• Practical
• Increased comfort 
for socially 
undesirable 
behaviors
• Minimizes data 
entry errors
• Immediate scoring, 
feedback
• Amenable to 
incorporation within 
EHR
• Cost
• Potential discomfort 
with technology
• Accessibility
• Measurement 
equivalence
Setting of administration
Clinic Patient completes 
PROMs when he or 
she arrives to clinic 
appointments
• Real-time 
assessment of 
outcomes
• Feasibility with 
use of electronic 
methods of 
administration
• Impact on clinic flow
• Interruptions 
resulting in missing 
data
• Patient anxiety
• Staff burden
(continued)
(continued)
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Modes and Methods Issues
Administering PRO instruments (PROMs) requires users to make decisions 
about three aspects of data collection (Figure 1): 
• Data source—i.e., the source of the PRO (the patient or, in some cases, a 
proxy or other reporter)
• Mode by which information was recorded—i.e., self-administered or 
interviewer-administered
• Method used to capture the information (such as paper-and-pencil 
questionnaire or telephone- or computer-assisted technologies). 
Each of these aspects is described below. These three aspects can be 
combined in various ways. For example, a patient might use the telephone 
to self-administer a PROM, or an interviewer might use a computer to read 
questions and record answers. 
Table 3. PRO methods: characteristics, strengths, and limitations
Methodological 
Issue
Main Characteristics Main Strengths Main Limitations
Setting of administration (continued)
Home Patient completes 
PROMs at home 
before or between 
clinic visits
• Minimizes impact 
on clinic flow
• Minimizes staff 
burden
• Accessibility
• Health information 
privacy
• Data security
• Patient safety
Other Patients complete 
PROMs at other 
types of settings 
(e.g., skilled nursing, 
rehabilitation)
• Feasibility with 
electronic methods 
of administration
• Cognitive capacity 
and potential need 
for proxy
Scoring
Classical test 
theory
Raw scores • Easy to implement 
and understand
• All items must be 
administered
Modern test 
theory
Probabilistic approach • Enables CAT 
(tailored questions)
• Shorter 
questionnaires with 
more precision
• Difficult to 
implement and 
understand
CAT, computer-assisted testing; EHR, electronic health record; PRO, patient-reported outcome; PROM, 
patient-reported outcome measure. 
Source: Data are from Data Collection Methods. Quality of Life and Pharmacoeconomics in Clinical Trials130 
and Psychological Aspects of Health-Related Quality of Life Measurement: Tests and Scales. Quality of Life and 
Pharmacoeconomics in Clinical Trials.131
(continued)
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The patient’s perspective is the focal point of PRO assessment. In some 
circumstances, directly obtaining this perspective may be difficult or 
impossible. In adults, cognitive and communications deficits and burden of 
disease, for example, can limit potential subjects’ ability to complete PROMs.110 
This is especially likely to occur with the elderly and with people of any age 
who have severe disease or suffer from neurological disorders. Children’s 
participation can be limited by these same factors plus issues specific to their 
age and developmental level.110–112 
Failing to include these populations can result in potentially misleading 
interpretations of results. Thus, attempting to include them in PRO assessment 
efforts is crucial. Using all possible mechanisms for obtaining self-reports is 
a high priority, but accomplishing this may be out of the question for some 
populations. 
Proxy Report as a Substitute for Self-Report
One way to include the greatest number of patients is to use proxy respondents 
to obtain PRO information for patients who are unable to respond. Using 
either significant others (e.g., parents, spouses or other family members, 
friends) or formal caregivers (physicians, nurses, aides, teachers) as proxies can 
provide many potential benefits. It not only allows inclusion of a broader and 
more representative range of patients in the entire measurement effort, but it 
can also help minimize missing data and increase the feasibility of longitudinal 
assessment. 
Data Source:
Self-report vs. Proxy/Observer
Mode: Method:
Self-administration • Paper-and-pencil
• Telephone
• ComputerInterviewer-administration
Figure 1. Types of respondent sources of data and modes and methods of 
administration
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The usefulness of proxy responses as substitutes for patient responses 
depends on the validity and reliability of proxy responses compared with 
those attributes for patient responses. When evaluating the quality of proxy 
responses, analysts usually compare proxy responses with patient responses. 
This is a reasonable approach, when proxy responses are being used to replace 
patient responses.
Agreement between the proxy and patient is typically assessed at either the 
subscale level, via the intraclass correlation coefficient (ICC), or the item level, 
by the kappa statistic, although other types of analyses have been advocated.113 
Patient and proxy responses are also often compared at the group level by 
comparing mean scores. Group comparisons help detect the magnitude and 
direction of any systematic bias that might be present.
Both the adult and pediatric literatures suggest that agreement between 
proxy and patient ratings is higher when rating observable functioning 
or HRQL dimensions such as physical and instrumental activities of daily 
living, physical health, and motor function. Agreement is typically lower 
for more subjective dimensions such as social functioning, pain, cognitive 
status or function, and psychological or emotional well-being.112,114–118 Using 
continuous rather than dichotomous ratings improves agreement.119 Extent of 
disagreement increases with increasing age of adolescents120 and as the severity 
of patient illness, cognitive impairment, or disability rises.121–124 Type of proxy 
(e.g., parent versus caregiver) and proxy characteristics such as age, education, 
and level of stress may also affect agreement.125,126 In terms of direction of 
disagreement, proxies for adults tend to rate them as having more symptoms, 
functional difficulties, emotional distress, and negative quality of life; the main 
exception is pain, about which proxies tend to under-report.114 Patterns of 
disagreement for child- versus proxy-reported outcomes are inconsistent.127 
Even when self- and proxy reports disagree for either children or adults, 
differences tend to be small.127,128 
Proxy Report as a Complement to Self-Report
Proxy assessment may substitute for patient assessment where needed, but 
it may also complement it. Proxies can be asked to assess the patient as they 
think the patient would respond (i.e., proxy-patient perspective), or they 
can be asked to provide their own perspective on the patient’s functioning 
or HRQL. This type of additional rating may be better described as either an 
external or “other” rating129 for the sake of clarity. An important consideration 
is that the measure make clear which perspective is desired.127 
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The external (i.e., “other”) perspective may provide particularly relevant 
information when the person is unable to provide any self-assessment, but 
it can be important even when the patient can give his or her own answers. 
In such cases, patient-other agreement may not necessarily be desirable. For 
example, patients in the earlier stages of dementia may be able to provide 
responses to PROMs but fail to recognize the extent of their impaired well-
being and physical role functioning. In such cases, a next-of-kin caregiver such 
as a spouse could provide an external assessment that indicates that the patient 
has some degree of problems in functioning, such as getting the groceries from 
car to kitchen or being comfortable in a social setting. In these circumstances, 
external (proxy) respondents can clearly introduce clinically important 
information. 
Mode: Self-Administration Versus Interviewer Administration
Self-administration of PROMs is neither expensive nor influenced by 
interviewer effects; for these reasons, this mode of administration has 
traditionally been preferred. However, self-administration is not feasible for 
some patient populations, such as those who may be too ill to self-administer 
a questionnaire. In these cases, interviewer administration is often required. 
Until recently, interviewer administration was also required for those with low 
literacy; however, new multimedia methods are now available to overcome this 
barrier.
Main Advantages and Disadvantages of Different Modes of 
Administration
Table 3 summarized the principal benefits and drawbacks of different modes 
of administration, based on authoritative sources.130,131 Self-administered 
instruments are more cost-effective from a staffing perspective, and they 
may yield more patient disclosure, especially when collecting sensitive 
information.132 Disadvantages include the potential for more missing data and 
the inability to clarify any misunderstandings in questions or response options. 
By contrast, interviewer-administered instruments allow for probes and 
clarification, and they permit more complexity in survey design (e.g., the use of 
complicated skip patterns or open-ended questions). This mode is also useful 
for persons with reading, writing, or vision difficulties. Disadvantages include 
the costs required to hire, train, and supervise interviewers and the potential 
pressure on respondents to answer quickly, rather than letting them proceed 
at their own pace. The potential for interviewer bias cannot be overlooked. 
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It may arise from systematic differences from interviewer to interviewer or, 
occasionally, systematic errors on the part of many or even all interviewers.133
Additional Concerns About Sources of Bias
Other sources of bias for both administration modes include social desirability 
response set (the tendency to give a favorable picture of oneself) and 
acquiescent response set (the tendency to agree or disagree with statements 
regardless of their content).134,135
Legitimate concerns arise about the potential biasing effects of mode 
of administration on data quality and interpretation.136 Overall, evidence 
supports high reliability for instruments administered with different modes, 
but response effects have varied and have not been consistently in the same 
direction.121–124 For example, some studies have reported more favorable reports 
of well-being on self-administered questionnaires,137 whereas others have 
found the opposite effect.138–140 Still other studies reported mixed results141 
or found no important differences attributable to mode of administration 
after adjusting for other factors.130,142,143 Fortunately, many types of error and 
bias can be overcome by appropriate selection and training of interviewers. 
Effects of different modes can also be evaluated with various psychometric and 
statistical techniques and models to determine the potential impact of response 
effects.144–148 
Method of Administration
Advances in technology have changed the face of PROM assessment, 
increasing the number of administration options available. Multiple methods 
of self-administration currently exist, and the different methods may have 
different effects on the quality of the data.136 Although diverse administration 
methods provide more options for researchers and clinicians, they require 
different skills and resources of people being asked to respond to the 
questionnaire. This means that the choice of method of administration may 
pose differing levels of respondent burden.136
Several factors may account for differences in data quality across methods 
of administration: impersonality of the method, cognitive burden on the 
respondent, ability to establish the legitimacy of the reasons for which patients 
or others are even being asked to complete a questionnaire, control over the 
questionnaires, and communication style.136 Thus, when users are deciding on 
one (or more) appropriate methods of administration for a given PROM, they 
must give these factors due consideration. 
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Historically, paper-and-pencil administration served as the primary method 
of PROM assessment. Many PROMs were originally developed with the 
intention of paper-based administration, but they may be (and typically are) 
amenable to an electronic-based administration.149 Paper-and-pencil remains a 
widely used PROM administration method, with its primary advantage being 
cost-effectiveness in situations in which users face few mailing and follow-up 
costs.
However, the paper-and-pencil method has disadvantages. For example, it 
may require that a person’s responses be manually entered into a database for 
scoring purposes, raising the possibility of data entry errors that threaten the 
integrity of the results. Similarly, the need for manual data entry and scoring 
can be time-intensive. Although the availability of optical mark recognition 
and optical character recognition allow scanning of paper-and-pencil PROMs, 
this process still requires an extra step on the part of staff and may limit the 
acceptability of paper-and-pencil administration for purposes in which timely 
scoring and interpretation are important. 
Advances in technology and the increasingly widespread availability of 
electronic resources have provided several alternatives to paper-and-pencil 
administration. Improved telephone technology has enabled the use of 
interactive voice response to administer PROMs. Interactive voice response 
involves a computer audio-recording of PROM questions administered via 
telephone to which people indicate their responses by selecting the appropriate 
key.136,149 
In addition, computer-based administration methods have emerged 
as feasible alternatives to paper-and-pencil, such as web-based platforms, 
touchscreen computers, and multimedia platforms that can accommodate 
people with a range of literacy and computer skills (e.g., Talking 
Touchscreen/la Pantalla Parlanchina, audiovisual computer-assisted self-
interviewing).136,149–151 Newer mobile forms of technology such as tablet 
computers and smartphones also offer promise as methods of PROM 
administration.
Electronic administration methods have advantages that contribute to 
their increasingly widespread adoption. For example, because patients or 
respondents enter the data themselves, the opportunity for data entry errors is 
minimal compared with paper-and-pencil administration with separate data 
entry. These electronic methods also typically allow for immediate scoring and 
feedback, which enhances applications requiring timely results. Furthermore, 
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electronic PROM administration has been shown to be practical, acceptable, 
and cost-effective.60 Electronic methods may also provide people with 
increased comfort when responding to questions about socially undesirable 
behaviors.152 
Nonetheless, these advantages must be considered in light of several 
important disadvantages. First, the cost of purchasing technology-based 
platforms may exceed that of traditional paper-and-pencil methods. 
Additionally, some patients may experience discomfort with technology or lack 
the skills necessary to navigate electronic administration methods. Moreover, 
reliance upon methods such as web-based platforms or smartphones raises 
questions about people’s access to these technologies, if they are not provided 
in the relevant settings as part of clinical practice, quality improvement, or 
other assessment efforts. 
The availability of multiple methods of PROM administration highlights 
the importance of measurement equivalence across methods.149 Measurement 
equivalence is determined by comparing the psychometric properties of data 
obtained via paper-based administration and data collected through electronic 
administration.149 It can be assessed via cognitive testing, usability testing, 
equivalence testing, or psychometric testing (or various combinations of these 
techniques).149 A growing body of research documents the equivalence of 
electronic and paper-and-pencil administration of PROMs.153–155 These findings 
support the viability of electronic PROM administration as an alternative to 
paper-and-pencil methods. 
In addition to measurement equivalence, patient privacy is another 
concern that cuts across both paper-and-pencil and electronic administration 
methods, albeit in differing ways. For paper-based PROMs, physical transfer 
of the PROM from patient to provider, as well as the physical existence of the 
completed PROM, may pose risks to the privacy and confidentiality of patients’ 
responses. Privacy also emerges as a concern about electronic methods, given 
potential security breaches related to transfer of data, computer errors, or 
unauthorized access to patient-reported data. These threats underscore the 
need for reliable and secure electronic platforms to protect patients’ privacy in 
the context of PROM assessment. 
Patient-Reported Outcome Measures in the Clinical Setting
Collecting PRO data as part of clinical care has become common.2,156–158 
Facilitating introduction of these PROMs into clinical practice and decision 
24  Patient-Reported Outcomes in Performance Measurement
making promises many benefits. Advocates for using PROMs in clinical care 
propose that the results assist clinical providers in managing their patients’ 
care,159 enhance the efficiency of clinical practice,155,160 improve patient-provider 
communication,155,160-162 identify patient needs in a timely manner,155, 163 and 
facilitate patient-centered care.155 Other findings, however, suggest regional 
variation in perceived health and no positive effect of feedback via PROMs on 
care, even when combined with guideline-recommended interventions.164–166 
As PROMs are used more in clinical practice, some methodological issues 
pertaining to the settings in which they are administered merit consideration.
A growing number of studies have investigated the use of PROMs in the 
clinic setting.155,160,162,163,167–170 When selecting PROMs for administration in 
clinical practice, users need to consider the efficiency of PROM administration, 
scoring, and interpretation. These factors are especially important because of 
the time-sensitive nature of the clinic workflow.155,167 In addition, acceptability 
of both the PROM and the data collection process for both patients and clinic 
staff is essential.155,167,171 
Historically, several barriers have impeded widespread implementation of 
PRO data collection in clinical settings of all sorts, but especially for smaller 
or private practices. Many drawbacks are associated with paper-and-pencil 
administration of PROMs. One such barrier involves concerns about the 
potential disruption to the clinical workflow if patients are asked to complete 
PROMs.159 In addition, staff burden and clinician disengagement may hamper 
obtaining PRO data in clinical settings.159 
Fortunately, technology advances, and the increased opportunities for 
methods of PROM administration that they afford, may help to overcome 
some barriers to PRO data collection in clinical practices and settings.167 For 
example, research supports the feasibility of using tablet computers155,163 and 
touchscreen computers for these purposes.150,151,162,167,168 Employing computers 
to administer PROMs may streamline and expedite the process and minimize 
staff burden and impact on clinic flow. 
Conversely, concerns arise regarding the impact of clinic flow on the 
integrity of data collection, given the potential for patients to be interrupted 
while completing PROMs, which could potentially result in missing 
data.159 Another potential barrier involves the possibility that patients may 
experience anxiety in completing PROMs in the clinical settings before their 
appointments.159 Similarly, a possible lack of privacy when completing PROMs 
in waiting rooms or similar circumstances poses another potential obstacle 
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to adequate PROM administration. Many of these concerns can be addressed 
by incorporating PROMs into the clinical workflow. This may also enhance 
completion rates. Both patients and providers will then be more likely to see 
this effort as integral to patient care. 
Completing PROMs from home before or between medical appointments 
has been proposed as one strategy to overcoming the problems outlined 
above.159,172,173 Both web-based PROM administration and interactive voice 
response constitute possible methods for at-home PRO data collection.151,161,162 
Although the home may serve as a feasible alternative to the clinical practice 
setting for various reasons, those considering implementing home-based 
PRO data collection need to consider several factors.159,172 First, for patients 
to be able to complete PROMs at home, they must have access to the type 
of technology by which the PROM is administered (e.g., Internet). Second, 
patients must find completing PROMs at home acceptable. Third, users 
should have a plan in place to address situations in which home-based PROM 
responses suggest critical or acute problems. This may pose a logistical 
challenge in comparison with PROMs completed in-clinic, where medical 
providers and access to intervention are readily available. 
As with any setting, health information privacy is paramount; therefore, 
one barrier to home-based PROMs is the availability of secure data 
collection platforms.159,174 Finally, an especially difficult issue may be clinician 
acceptability of home-based PRO data collection. The problems include 
reimbursement for clinicians’ time using a website to address outcomes that 
patients report, rather than meeting directly with patients to discuss questions 
or problems that their patients raise through answers to the PROMs.159,174
Implementing PRO data collection in other settings, such as rehabilitation 
or skilled nursing facilities, may also yield valuable clinical information and 
guide interventions. Less research has addressed the issues in administering 
PROMs in these settings. However, handheld technology may offer a means 
of facilitating collection of PRO data in the rehabilitation setting following 
orthopedic surgery.175
Apart from technology per se, other issues in such facilities include the 
varying level of patients’ acuity status and levels of cognitive capacity to 
complete PROMs. In these cases, users may need to consider whether using 
proxy reports may be beneficial. In any case, the potential strengths and 
weaknesses of different modes and methods of administration still need to be 
taken into account. 
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Scoring: Classical Test Theory Versus Modern Test Theory
Many PROMs involve the measurement of latent (not directly observable) 
variables; examples might include symptoms (not signs) of gastrointestinal 
disease or pain. The only way to estimate a person’s level on a particular 
attribute is by asking questions that represent the attribute in question. Most 
PROMs comprise multiple items that are aggregated in some way to produce 
an overall score. The most common multi-item instruments are designed to 
reflect a single underlying construct. The item responses either are caused by or 
are manifestations of the underlying latent attribute, and the items are expected 
to correlate with one another.176–179 
In some other kinds of multi-item measures, the items may cluster together 
but would not be expected to correlate. A common example of this latter 
measure is a comorbidity index comprising various health conditions, e.g., 
diabetes, asthma, and heart disease. Another example might be a measure of 
access to care consisting of problems with paying for care, having a regular 
provider, ease of transportation to care, and ease of making an appointment. 
Although such items would not necessarily be correlated, together they might 
form an adequate measure of access. The discussion on scoring below refers 
to the former type of instrument reflecting underlying constructs with items 
expected to correlate with one another.
Scoring is based on classical test theory (raw scores) or modern test theory 
(item response theory [IRT]).180–189 Multiple items are preferred because a 
response to a single item provides only limited information to distinguish 
among individuals.190 In addition, measurement error (the difference between 
the true score and the observed score) tends to average out when responses to 
individual items are summed to obtain a total score.190–192
Classical test theory estimates the level of an attribute as the sum, 
perhaps weighted, of responses to individual items, i.e., as a linear 
combination.13,190,193–196 This approach requires all items on a particular 
PROM to be used in every situation for it to be considered valid. Hence, the 
instrument is test-dependent.194,196–198 
IRT, by contrast, enables test-free measurement; i.e., the latent trait can 
be estimated using different items as long as their locations (difficulty levels) 
have been calibrated on the same scale as the patients’ ability levels.13,190,196–201 
IRT allows computer-adaptive testing (CAT) in which the number, order, and 
content of the questions are tailored to the individual patient. This approach 
has two distinct advantages: (1) questionnaires can be shorter, and (2) the 
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scale scores can be estimated more precisely for any given test length. This also 
means that different patients do not need to complete the same set of items in 
every situation.13
Using IRT poses nontrivial challenges, however. Understanding the 
assumptions and the psychometric jargon—e.g., “calibration,” “difficulty 
levels”—is not easy. The methodology and software are complex. IRT is also 
not appropriate for causal variables and complex latent traits.13,196,197,202 Overall, 
however, IRT offers a very convenient and efficient framework for PRO 
measurement, and it is becoming increasingly well understood and easier to 
adopt.
Linking or Cross-Talk Between Different Measures of the Same 
Construct
A common problem when using an array of health-related outcomes for 
diverse patient populations and subgroups is establishing the comparability of 
scales or units on which the outcomes are reported.203,204 Typically the metric 
has been emphasized more than the measure. Equating is a technique to 
convert the system of units of one measure to that of another. Analysts have 
successfully used this process of deriving equivalent scores in educational 
testing to compare test scores obtained from parallel or alternate forms that 
measure the same characteristic with or without having common anchor items. 
Theoretically (and in practice when certain conditions are met), different 
age-specific measures could be linked, thus placing child, adult, and geriatric 
estimates on a common metric. For example, the many items that constitute 
a condition-specific (e.g., cancer) quality of life scale could be incorporated 
into a single shared bank and linked through a common-anchor design.203 
The methods of establishing comparable scores—often called linking—vary 
substantially depending on the definition of comparability. For that reason, 
standardization is critical in comparing PROMs across studies. Two measures 
may be considered linked if they produce scores that match the first two 
moments of their distributions (i.e., mean and standard deviation for a specific 
group of examinees or two randomly equivalent groups). Another definition 
may involve matching scores with equal percentile ranks based on a single 
sample of examinees or random samples drawn from the same population. 
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Addressing Barriers to Patient-Reported Outcomes 
Measurement
Users need to address yet other barriers to PRO measurement. These include 
administering PROMs in vulnerable populations; literacy, health literacy, 
and numeracy; language and cultural differences; differences in functional 
abilities; response shift; use of different methods and modes of administration; 
and the impact of nonresponders to items and questionnaires. In discussing 
these issues below, we also note best practices and recommendations for 
addressing them. 
Vulnerable Populations
Recognition is growing that some population subgroups are particularly 
vulnerable to receiving suboptimal health care and to failing to achieve health 
outcomes equivalent to those experienced by the general population.205–207 
Vulnerability is multifaceted. It can arise from age, race, ethnicity, or sex (or 
gender); health, functional, or developmental status; financial circumstances 
(income, health insurance); place of residence; or ability to communicate 
effectively.205 Moreover, many of these factors are synergistic, so that 
vulnerability has many sources that present a complicated picture for persons 
in these groups. This definition encompasses populations who are vulnerable 
because of a chronic or terminal illness or disability and those with literacy or 
language difficulties.150,206 It also includes people residing in areas with health 
professional shortages.168
Administration of PROMs is usually performed with paper-and-pencil 
instruments, and multilingual versions of questionnaires are often not 
available. Interviewer administration is labor-intensive and cost-prohibitive 
in most health care settings. Therefore, patients with low literacy, those with 
certain functional limitations, and those who do not speak English are typically 
excluded, either explicitly or implicitly, from any outcome evaluation in a 
clinical practice setting in which patient-reported data are collected on forms.
As PROs continue to play a greater role in medical decision making 
and evaluation of the quality of health care, sensitive and efficient methods 
of measuring those outcomes among underserved populations must be 
developed and validated. Minority status, language preference, and literacy 
level may be critical variables in differentiating those who receive and respond 
well to treatment from those who do not. These patients may experience 
different health outcomes because of disparities in care or barriers to care. 
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Outcome measurement in these patients may provide new insight into 
disease or treatment problems that may have gone undetected simply because 
many studies have not been able to accommodate the special needs of such 
patients.206,208
Literacy
Low literacy is a widespread but neglected problem in the United States. 
The 1992 National Adult Literacy Survey (NALS)209 and the 2003 National 
Assessment of Adult Literacy (NAAL)210 measured three kinds of English 
language literacy tasks that adults encounter in daily life (prose literacy, 
document literacy, quantitative literacy). Almost half of the adult population 
experiences difficulty in using reading, speaking, writing, and computational 
skills in everyday life situations. An additional seven million adults in the US 
population were estimated to be nonliterate in English. Generally speaking, 
health literacy problems complicate matters of both health care delivery and 
PRO measurement.211,212
Health literacy is “the degree to which individuals have the capacity 
to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions.”213 This involves using a range 
of skills (e.g., reading, listening, speaking, writing, numeracy) to function 
effectively in the health care environment and act appropriately on health care 
information.214, 215 Limited health literacy is widespread214,216 and is associated 
with medication errors, increased health care costs, hospitalizations, increased 
mortality, decreased self-efficacy, and inadequate knowledge and self-care for 
chronic health conditions.211,214,217–219 Health literacy may be more limiting than 
functional literacy because of the unfamiliar context and vocabulary of the 
health care system.212,214,220
Contributing to poor understanding of the importance of literacy skills 
is the fact that low literacy is often underreported. The NALS reported that 
66 percent to 75 percent of adults in the lowest reading level and 93 percent to 
97 percent in the second-lowest reading level described themselves as being 
able to read or write English “well” or “very well.”209 In addition, low-literacy 
individuals are frequently ashamed of their reading difficulties and try to hide 
the problem, even from their families.221,222 Lack of recognition and denial of 
reading problems create a barrier to health care. Some low-literacy patients 
have acknowledged avoiding medical care because they are ashamed of their 
reading difficulties.221,222 In addition, because everyday life may place only 
moderate reading demands on people, individuals may not even be aware of 
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their reading problems until a literacy-challenging event occurs (e.g., reviewing 
treatment options, reading a consent document, completing health assessment 
forms).221,222
A reader’s comprehension of text depends on the purpose for reading, the 
ability of the reader, and the text that is being read. Two important factors in 
the readability of text are word familiarity and sentence length.223 Unfamiliar 
words are difficult when first encountered. Long sentences are likely to contain 
more phrases or clauses. Although longer sentences may communicate more 
information and more ideas, they are more difficult for readers to manage 
than more, but shorter, sentences that convey the same information. Moreover, 
longer sentences may also require the reader to retain more information in 
short-term memory.224–227
Addressing health literacy is now recognized as critical to delivering 
person-centered health care.228 It is an important component of providing 
quality health care to diverse populations, and it will be incorporated into the 
National Standards for Culturally and Linguistically Appropriate Services.229 
For example, translating highly technical medical and legal language into easily 
understood language is challenging, whether into English or another language. 
Health literacy practices are also included in the National Quality Forum 
2010 updated set of safe practices.76 A recent discussion paper summarized 
10 attributes that exemplify a “health literate health care organization.”228 
These attributes cover practical strategies across all aspects of health care, 
from leadership planning and evaluation, to workforce training, to clear 
communication practices for patients. 
Language and Culture 
The availability of multiple language versions of PROMs has enabled users to 
administer them relatively routinely in diverse research and practice settings. 
For various purposes, doing analyses on data that have been pooled across 
all patients is desirable. Yet concern is often voiced about combining data 
from different cultures or languages.10 In some research and practice-based 
initiatives, evaluating cross-cultural differences in PROMs is of interest. In 
all these applications, researchers must use unbiased questionnaires that can 
detect important differences among patients.206,230,231 
Possible cultural differences in interpreting questions and in response styles 
may limit data pooling or may constrain comparisons across members of 
different cultural groups.232–234 Similarly, poor quality translations can produce 
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noncomparable language versions of PROMs.233,235,236  For a questionnaire to be 
suitable for use as an unbiased measure of a PRO, items in the questionnaire 
must perform similarly across different groups (i.e., they must be cross-
culturally or cross-linguistically equivalent).231,237–248 Without assurances that 
the PROM is culturally and linguistically “fair,” detected treatment differences 
caused by items that function differently across groups could incorrectly 
be interpreted to reflect real treatment differences. Similarly, differences in 
questionnaire performance may mask true treatment differences, especially 
when language or cultural groups are not balanced across the populations, 
practices, or settings to be compared. 
Functional Abilities
Ideally, PROMs that are intended to be used in performance measurement 
applications can be completed by all patients in the target populations. 
Otherwise, if a significant proportion of the population is left out, the 
remaining individuals being assessed may be unrepresentative of the whole 
practice or setting. This problem can (and probably will) compromise the 
validity of the performance measure. 
Functional limitations associated with disability are one type of potential 
barrier to PRO assessment that could affect PRO use in performance 
measurement. The prevalence of disability, defined as specific functional or 
sensory limitations, is estimated at 47.5 million Americans, or 22 percent of 
the US population.249 People with a disability are more likely to develop health 
conditions and be consumers of health care than those with no disabilities of 
these types. Thus, they are an important group to include when evaluating 
health care, but one that is frequently not included in such clinical, quality 
improvement, or simulation initiatives.250,251
Common disabilities that can affect PROM assessment include problems 
with vision (e.g., decreased visual acuity, color-blindness), hearing, motor 
skills (e.g., upper extremity limitations), and cognitive deficits (e.g., impaired 
comprehension, reading). Fortunately, to address many of these barriers, 
those administering such measures have a variety of techniques: choosing 
appropriate methods and modes of data collection, enabling use of assistive 
devices and technology, and using principles of universal design when 
developing instruments.201–202
Universal design refers to designing products and environments in such 
a way that all people can use them, to the greatest extent possible, without 
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adaptation or specialization.252,253 A well-known example of universal design 
is the use of curb cuts. Initially intended to facilitate the use of wheelchairs, 
curb cuts have also benefited bicycle riders and people pushing children 
in strollers, among others. An exhaustive examination of how to apply the 
principles of universal design to PROM assessment is beyond the scope of this 
paper, and those developing or modifying measures according to the principles 
of universal design are encouraged to consult with relevant experts. Also, if 
developers are creating an instrument based on information technologies, 
using the standards in Section 508 of the Rehabilitation Act Amendments of 
1998 can maximize flexibility.254 Although we cannot list all potential ways to 
address functional limitations, we identify below some common ways to do so. 
Harniss and colleagues describe how PROMIS is taking a systematic approach 
to enhancing accessibility.255
In general, providing multiple means of understanding and responding to 
measures is important. These include visual, voiced, and tactile mechanisms. 
The specific means may differ depending on the method and mode of 
administration. 
For instance, for people with impaired vision, one might consider using 
in-person or telephone interviews (advantages and disadvantages discussed 
in an earlier section), an interative voice response system, Braille responses 
for Braille users, or touchscreen with tactile or audio cues. Information 
technology-based systems should accommodate assistive devices such as 
screen readers and screen-enlargement software. For patients with hearing 
impairments, options include providing visual presentation of words or images, 
using TTY (text telephones) or a video relay service, and allowing the user to 
adjust the sound level. For persons with motor limitations, response modes 
that are easier to manipulate (track ball) or are nonmotoric (e.g., using voice 
recognition software) can be helpful. For those with certain types of cognitive 
deficits (e.g., limited reading comprehension), the methods to address literacy 
described earlier should be considered. However, if cognitive deficits are 
severe, a proxy respondent may be more appropriate.
Allowing for multiple response modes or methods may lead to 
measurement error. In a later section, we discuss the potential impact of 
different methods and modes on response rate, reliability, and validity. The risk 
of introducing measurement error seems outweighed by the risk of excluding a 
significant segment of the population.
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Response Shift, Adaptation, and Other Challenges to Detecting True 
Change
The ability to detect true change over time in PROMs poses another barrier 
to the integrity of valid PRO assessment. Often, detecting true change is 
associated with the phenomenon of response shift.  This has been defined as 
“a change in the meaning of one’s self-evaluation of a target construct as a 
result of: (a) a change in the respondent’s internal standards of measurement 
(i.e., scale recalibration); (b) a change in the respondent’s values (i.e., the 
importance of component domains constituting the target construct); or (c) a 
redefinition of the target construct (i.e., reconceptualization).”256,p.1532 A change 
in perspective over time may result in patients’ attending to PROMs in a 
systematically different way from one time point to another.257
Response shift serves as a barrier to PRO assessment for several important 
reasons. For example, it threatens longitudinal PRO assessment validity, 
reliability, and responsiveness.257–260 Response shift can complicate the 
interpretation of PROM scores; a change in a PROM may occur because of 
response shift, an effect of treatment, or both.261
Monitoring for response shift can aid PROM users in interpreting 
longitudinal PRO data.259 Several strategies have been proposed to identify 
response shift, although each has limitations. The “then test” compares an 
actual pre-test rating and a retrospective pre-test rating to assess for shift, 
but it is less robust than other methods of detecting response shift257 and it is 
confounded with recall bias.260 Structural equation modeling has also been 
proposed as a way to identify response shift, but it is sensitive only if most 
of the sample is likely to make response shifts.262 Finally, growth modeling 
creates a predictive growth curve model to investigate patterns in discrepancies 
between expected and observed scores, thus assessing response shift at the 
individual level.263 Although growth modeling enables users to detect both the 
timing and shape of response shift,259 it cannot differentiate between random 
error and response shift.260
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Implications of the Different Methods and Modes for 
Response Rate, Reliability, and Validity
Implementing Data Collection Methods
Users of PROMs must make a variety of decisions about the data collection 
method and the implications of those decisions on costs and errors in 
surveys.132 Two basic issues underlie these decisions: What is the most 
appropriate method to choose for a particular question, and What is the 
impact of a particular method on survey errors and costs? 
Methods differ along a variety of dimensions.132 These include, although 
are not limited to, the degree of interviewer involvement and the level of 
interaction with the respondent. Channels of communication (sight, sound, 
touch) may prompt different issues of comprehension, memory stimulation, 
social influence affecting judgment, and response hurdles. Finally, the degree of 
technology use is a major consideration.
Using Different Method or Mode Than the One Originally Validated
Considering the implications of using a different method or mode than the 
one on which the PROM was originally validated is also important. Many 
existing PROMs were initially validated in paper-and-pencil form. However, 
potential differences exist between paper-and-pencil and electronic-based 
PROM administration, ranging from differences in how items and responses 
are presented (e.g., items presented one at a time, size of text) to differences in 
participant comfort level in responding (e.g., ability to interact with electronic-
based platforms).153
As noted earlier, a growing body of research suggests measurement 
equivalence between paper- and computer-administered PROMs.153,264 
However, the effect of a particular data collection method on a particular 
source of error may depend on the specific combination of methods used.132 
Thus, as new methods are developed, studies comparing them with the 
methods they may replace must be done. 
In framing expectations about the likely effect of a particular approach, 
developers need to invoke theories about that approach. Theory is informed 
by past mode-effects literature and by an understanding of the features or 
elements of a particular design.132 Similarly, mode choices involve trade-offs 
and compromises. Therefore, the choice of a particular approach must be made 
within the context of the particular objectives of the survey and the resources 
available.132
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Using Multiple Methods and Modes
The implications of using multiple methods and modes also warrant 
consideration. One might choose to blend methods for one or more reasons: 
cost reduction, faster data collection, optimization of response rates.132 
When combining methods or modes (or both), users must ensure that they 
can disentangle any effects of the method or mode from other population 
characteristics. This is especially true when respondents choose which method 
or mode they prefer or when access issues determine the choice of method or 
mode.132 As in the case of using a different method or mode than the one in 
which the PROM was originally validated, instruments and procedures should 
be designed with an eye to ensuring equivalence across both methods and 
modes.265
Accounting for the Impact of Nonresponders
Difficulties with data collection and questionnaire completion are major 
barriers to the successful implementation of PRO assessment. The principal 
problem is that missing data can introduce bias in analyses, findings, and 
conclusions or recommendations.13 The choice of mode and method of 
questionnaire administration can affect nonresponse rates and nonresponse 
bias.132 In addition, often the timing of the assessment can be very important, 
e.g., just before or just after surgery.
Missing data may be classified as either item nonresponse (one or more 
missing items within a questionnaire) or unit nonresponse (the whole 
questionnaire is missing for a patient). Evaluating the amount of, reasons for, 
and patterns of missing data is important.266–269 Some common strategies to 
evaluate nonresponse bias include
• conducting an abbreviated follow-up survey with initial 
nonrespondents132 
• comparing characteristics of respondents and nonrespondents270,271 
• comparing respondent data with comparable information from other 
sources272 
• comparing on-time vs. late respondents.273
When dealing with missing data, analysts can use various statistical 
methods of adjustment. For item nonresponse in multi-item scales, several 
useful techniques tend to yield unbiased estimates of scores: simple mean 
imputation, regression imputation, and IRT models. For both item and unit 
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nonresponse, it is important to determine whether missing data are considered 
to be missing completely at random (MCAR), missing at random (MAR), 
or missing not at random (MNAR).266,267 For unit nonresponse, users can 
implement a range of statistical techniques, depending on the reason for 
missing data.274–278 
Selection of Patient-Level PROMs
Patient-Centered Outcomes Research
An essential aspect of patient-centered outcomes research (PCOR) is the 
integration of patient perspectives and experiences with clinical and biological 
data collected from the patient to evaluate the safety and efficacy of an 
intervention. Such integration recognizes that although traditional clinical 
endpoints such as laboratory values or survival are still very important, we 
also need to look at how disease and treatment affects patients’ health-related 
quality of life (HRQL). For such HRQL endpoints, in most cases, the patients 
are the best source for reporting what they are experiencing. The challenge is 
how best to capture patient data in a way that maximizes our ability to inform 
decision making in the research, health care delivery, and policy settings.
Access to psychometrically sound and decision-relevant PROMs 
will allow clinicians, investigators, administrators, and others to collect 
empirical evidence on the differential benefits and harms of a health-related 
intervention.279–282 Those obtaining such information can then disseminate 
findings to patients, clinicians and health care professionals, payers or insurers, 
and policy makers. Doing so may provide a richer perspective on the net 
impact of interventions on patients’ lives using endpoints that are meaningful 
to the patients.283
Increasingly, longitudinal observational and experimental studies have 
included PROMs. To optimize decision making in clinical care, users 
must assess these PROMs in a standardized way, using questionnaires that 
demonstrate specific measurement properties.279,282,284–287 Our group recently 
identified minimum standards for the design or selection of a PROM for use 
in PCOR activities.288 Central to this work was understanding which attributes 
would make a PROM appropriate or inappropriate for such purposes. We 
identified these standards through two complementary approaches. The first 
was to conduct an extensive review of the literature including both published 
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and unpublished guidance documents. The second was to assemble a group of 
international experts in PROMs and PCOR efforts to seek consensus on the 
minimum standards.288 
Attributes of PROMs
Many documents summarize attributes of a good HRQL measure. They 
include (an illustrative list) guidance documents from the FDA;289–292 the 
2002 Medical Outcomes Trust guidelines on attributes of a good HRQL 
measure;293 the extensive, international expert-driven recommendations 
from COSMIN (COnsensus-based Standards for the selection of health 
Measurement INstruments);285,294–298 the EORTC (European Organization for 
Research and Treatment of Cancer) guidelines for developing questionnaires;299 
the Functional Assessment of Chronic Illness Therapy (FACIT) approach;36 
the International Society for Pharmacoeconomics and Outcomes Research 
(ISPOR) task force recommendation documents;149,241,300,301 and several 
others.245,284,302–304 Since 2010, ISOQOL (the International Society of Quality of 
Life) has completed two important guidance documents on use of PROMs in 
comparative effectiveness research and on integrating PROMs in health care 
delivery settings.284,305 Finally, the NIH PROMIS network released a standards 
document in 2012 that is useful for informing the minimal and optimal 
standards for designing PROMs.306
Table 4 presents long-established criteria to consider in selecting PROMs for 
research, quality improvement activities, and now performance measurement. 
It specifies issues that PROM users need to consider when contemplating 
incorporating PROMs into performance measures and offers some best 
practices for evaluating PROMs in this context. 
The eight primary criteria are the following: (1) conceptual or measurement 
model; (2) reliability and its subparts (e.g., internal consistency reliability); 
(3) validity and its subparts (e.g., content validity); (4) how scores are 
interpreted; (5) burden placed on respondents; (6) alternative modes and 
methods of administration; (7) cultural and language adaptations; and (8) use 
of electronic health records (EHRs). The table does not specify key issues and 
best practices for reliability or validity; that information is given only for the 
subcriteria. We illustrate these points with selected information pertaining 
to the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC).307
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Table 4. Primary criteria for evaluating and selecting patient-reported 
outcome measures (PROMs) for use in performance measurement 
Criteria and Subcriteria for 
Evaluating PROMs
Specific Issues to Address for Performance 
Measures and Best Practices in Assessing 
Candidate PROMs
Example: The 
Western Ontario and 
McMaster Universities 
Osteoarthritis Index 
(WOMAC)307 for Use in 
Hip Arthroplasty
1. Conceptual and Measurement Model
• Documentation should 
define and describe the 
concept(s) included 
and the intended 
population(s) for use.
• Documentation 
should explain 
how the concept(s) 
are organized into 
a measurement 
framework, including 
evidence for the 
dimensionality of 
the measure, how 
items relate to each 
measured concept, 
and the relationships 
among concepts.
• Target PRO concept should be a high 
priority for the health care system and 
patients. 
• Patient engagement should define 
what an important concept to 
patients is.
• Target PRO concept must be 
actionable in response to the health 
care intervention. 
• Patient input was 
used to evaluate 
the dimensionality 
and the importance 
of concepts to be 
measured.308
• Evidence suggests 
that some items 
measure the 
theoretically 
different concepts 
of physical function 
and pain load 
together on the 
same factor.309
2. Reliability
Documentation should 
specify the degree to 
which an instrument is 
free from random error.
Adequate levels of reliability are 
prerequisites for determining the 
potential use of any PROM.
See 2a and 2b for 
WOMAC examples.
2a. Internal consistency (multi-item scales)
Documentation should 
be provided about the 
reliability of a multi-item 
scale each time it is used; 
this should include the 
sample size, the number 
of items, and the specific 
reliability coefficient 
used.
Classical test theory (CTT) typically relies 
on the following values:
• Reliability estimate ≥ 0.70 for group-
level scores
• Reliability estimate ≥ 0.90 for 
individual-level scores
Item response theory (IRT) typically uses 
the following:
• Item information curves that 
demonstrate precision189
• A formula that can be applied to 
estimate CTT reliability.
Cronbach’s alphas for 
the three subscales 
(pain, stiffness, and 
physical function) 
range from 0.86 to 
0.98.310–312
(continued)
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Table 4. Primary criteria for evaluating and selecting patient-reported 
outcome measures (PROMs) for use in performance measurement 
Criteria and Subcriteria for 
Evaluating PROMs
Specific Issues to Address for Performance 
Measures and Best Practices in Assessing 
Candidate PROMs
Example: The 
Western Ontario and 
McMaster Universities 
Osteoarthritis Index 
(WOMAC)307 for Use in 
Hip Arthroplasty
2. Reliability (continued)
2b. Reproducibility (stability over time)
Documentation should 
be provided about the 
specific reproducibility 
estimate used and the 
justification for the 
length of time between 
assessments.
For evaluating trends or changes 
over time, an adequate level of 
reproducibility is a prerequisite for 
determining the potential use of any 
PROM.
Test-retest reliability 
has been adequate 
for the pain and 
physical function 
subscales, but less 
adequate for the 
stiffness subscale.312
3. Validity
Documentation should 
explain the degree to 
which the instrument 
reflects what it is 
supposed to measure.
• A limited number of PROMs have 
been validated for performance 
measurement. 
• PROMs should include questions that 
are patient-centered. 
See 3a, 3b, and 3c  for 
WOMAC examples.
3a. Content Validity
Documentation should 
explain the extent 
to which a measure 
samples a representative 
range of the content 
that it is supposed to 
cover, whether for the 
populations, settings, or 
other elements of the 
measurement task.
A PROM should have evidence 
supporting its content validity, including 
evidence that patients or experts (or 
both) consider the content of the PROM 
relevant and comprehensive for the 
concept, population, and aim of the 
measurement application. Meeting this 
criterion may entail:
• documenting the qualitative or 
quantitative methods (or both) used 
to solicit and confirm attributes 
(i.e., concepts measured by the 
items) of the PROM relevant to the 
measurement application. 
• documenting the characteristics of 
participants included in the evaluation 
(e.g., race/ethnicity, culture, age, 
socioeconomic status, literacy).
• documenting sources from which 
items were derived, modified, 
and prioritized during the PROM 
development process.
• giving an adequate justification for 
the recall period for the measurement 
application.
Development 
involved expert 
clinician input, 
survey input from 
patients,308 and a 
review of existing 
measures.
(continued)
(continued)
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Table 4. Primary criteria for evaluating and selecting patient-reported 
outcome measures (PROMs) for use in performance measurement 
Criteria and Subcriteria for 
Evaluating PROMs
Specific Issues to Address for Performance 
Measures and Best Practices in Assessing 
Candidate PROMs
Example: The 
Western Ontario and 
McMaster Universities 
Osteoarthritis Index 
(WOMAC)307 for Use in 
Hip Arthroplasty
3. Validity (continued)
3b. Construct and Criterion-Related Validity
Documentation should 
explain how the 
PROM meets standard 
requirements for these 
two types of validity, 
giving appropriate 
evidence (empirical 
findings).
A PROM should have evidence that 
• supports predefined hypotheses 
about the expected associations 
among measures that are similar to or 
dissimilar from the measured PRO.
• supports predefined hypotheses of 
the expected differences in scores 
between or among “known” groups.
• shows the extent to which scores 
of the instrument are related to a 
criterion measure.
• Patient ratings of 
satisfaction with 
arthroplasty were 
correlated with 
WOMAC scores 
in the expected 
direction.30,313, 314
• Scores 
differentiated 
between patients 
with better versus 
worse outcomes 
after knee 
arthroplasty30 and 
between patients 
with less versus 
more severe 
osteoarthritis.315
3c. Responsiveness
For longitudinal 
initiatives or applications, 
documentation 
should explain how 
the PROM can detect 
change over time and 
change in response to 
an intervention (i.e., 
empirical findings 
of changes in scores 
consistent with 
predefined hypotheses 
regarding changes in the 
target population).
• If a PROM has cross-sectional data that 
provide sufficient evidence in regard 
to the reliability (internal consistency), 
content validity, and construct validity 
but has no data yet on responsiveness 
over time (i.e., ability of a PROM to 
detect changes in the construct 
being measured over time), users 
need to consider carefully whether 
such a measure is likely to provide 
valid data over time in a longitudinal 
study, especially if no other PROM is 
available.
• Emphasizing responsiveness is 
important because of the expectation 
that care will have consequences. 
If action is to be taken, then 
demonstrating responsiveness is 
important. 
• PROMs must be sensitive to detect 
change in response to the specific 
health care intervention.
Responsiveness 
and ability to 
detect change in 
response to clinical 
intervention are both 
adequate.316
(continued)
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Table 4. Primary criteria for evaluating and selecting patient-reported 
outcome measures (PROMs) for use in performance measurement 
Criteria and Subcriteria for 
Evaluating PROMs
Specific Issues to Address for Performance 
Measures and Best Practices in Assessing 
Candidate PROMs
Example: The 
Western Ontario and 
McMaster Universities 
Osteoarthritis Index 
(WOMAC)307 for Use in 
Hip Arthroplasty
4. Interpretability of Scores
Documentation should 
support and assist users 
in interpreting scores 
from the PRO measure, 
including:
• What low and high 
scores represent for the 
measured concept
• Representative 
mean(s) and standard 
deviation(s) in the 
reference population
• Guidance on the 
minimally important 
difference in scores 
between groups or 
over time (or both) 
that can be considered 
meaningful from 
patient and clinical 
perspectives.
• If different PROMs are used, 
establishing a link or crosswalk 
between them is important.
• Because the criteria for assessing 
clinically important change in 
individuals do not directly translate to 
evaluating clinically important group 
differences,317 a useful strategy is to 
calculate the proportion of patients 
who experience a clinically significant 
change.280,317
• Population-based, 
age- and sex- (or 
gender-) normative 
values are 
available.318
• Minimal clinically 
important 
improvement 
values are 
available.319
• Instrument can 
be translated into 
a utility score for 
use in economic 
and accountability 
evaluations.320
5. Burden
Documentation should 
specify the time, effort, 
and other demands on 
both the respondent and 
the administrator.
• In a busy clinic setting, PRO 
assessment should be as brief as 
possible, and reporting should be 
done in real time.
• Patient engagement should inform 
what constitutes “burden.”
• Short form is 
available.321
• Average time to 
complete mobile 
phone WOMAC is 
4.8 minutes.322
6. Alternative Modes and Methods of Administration
Documentation should 
specify participant and 
administration burden 
and information about 
comparability across the 
modes and methods of 
administration.
Using multiple modes and methods 
can be helpful for diverse populations. 
However, evidence regarding their 
equivalence is needed.
Validated mobile 
telephone- and 
touchscreen-based 
platforms are 
available.323,324
(continued)
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Important Differences in PROM Attributes
Selecting PROMs for use in performance measurement and related activities 
such as quality improvement programs raises the question of what are the 
key differences, if any, when selecting PROMs for research purposes rather 
than these other nonresearch purposes. Generally speaking, the factors to 
consider when selecting PROMs for performance measurement and quality 
improvement activities are more similar than different. Thus, we focus here 
more on the differences that users will need to take into account.
Instrument Length
One key difference involves the length of the PROM. Longer questionnaires 
may be better tolerated in the context of research than in clinical practice 
settings; thus, to facilitate widespread adoption, PROMs for performance 
measurement should be short surveys. Addressing the need for shorter PROMs 
may, however, compromise other important measurement characteristics, such 
as reliability (i.e., precision and reproducibility). 
Table 4. Primary criteria for evaluating and selecting patient-reported 
outcome measures (PROMs) for use in performance measurement 
Criteria and Subcriteria for 
Evaluating PROMs
Specific Issues to Address for Performance 
Measures and Best Practices in Assessing 
Candidate PROMs
Example: The 
Western Ontario and 
McMaster Universities 
Osteoarthritis Index 
(WOMAC)307 for Use in 
Hip Arthroplasty
7. Cultural and Language Adaptations
Documentation should 
describe methods to 
evaluate cultural and 
linguistic equivalence.
The mode, method, and question 
wording must yield equivalent 
estimates of PRO measures.
Instrument is 
available in more 
than 65 languages.325
8. Electronic Health Records
Documentation 
should describe key 
considerations for 
incorporation into 
electronic health records.
Critical features include:
• Interoperability
• Automated, real-time measurement 
and reporting
•  Sophisticated analytic capacities.
Electronic data 
capture may allow 
for integration within 
electronic health 
records.322
Note: This table is adapted from recommendations in a report from the Scientific Advisory Committee 
of the Medical Outcomes Trust293 and a report submitted to the Methodology Committee of the Patient 
Centered Outcomes Research Institute.288 We adapted the key points from these sources to enhance 
relevance to PRO selection for performance measurement.
(continued)
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Implications of PRO Data for Action
Another key difference in factors to consider when selecting PROMs for 
clinical practice quality improvement, or performance measurement and 
accountability efforts, is the implications or consequences of the PRO data. 
Specifically, using PROMs for these purposes carries the expectation that 
important consequences will arise in terms of accountability for health care 
professionals, health care systems and plans, and clinical settings. Therefore, 
the stakes of PROMs are higher in the performance measurement context than 
in research applications. 
The problem lies, in part, in the constraints to the quality of the 
measurement level arising from factors unique to performance measurement.  
These can include instrument length or representativeness of the patient 
or consumer populations surveyed. These considerations highlight the 
importance of emphasizing responsiveness and sensitivity to change when 
considering PROMs for use in the ways envisioned for NQF-endorsed 
measures.
History of Successful Use of PROMs
In selecting a PROM for these various purposes, a logical first step involves 
reviewing what measures have already been used successfully. Using PROMs 
for these programs remains an understudied area, but several examples of 
PROMs used as indexes of performance measurement provide an initial 
foundation upon which the field can expand. 
The Veterans Health Study assessed PROs within the Veterans Health 
Administration (VA) system.326 In response to the VA’s incorporation of 
patient-reported functional status as a domain of interest in their performance 
measurement system, the Veterans RAND 36-Item Health Survey (VR-36) and 
the Veterans Rand 12-Item Health Survey (VR-12) have been administered 
within the VA system to evaluate veterans’ needs and to assess outcomes of 
clinical care at the hospital, regional, and health care system levels.326,327 The 
Centers for Medicare & Medicaid Services (CMS) and its Medicare Advantage 
Program328 have applied these methods for similar purposes, and CMS has 
also designated the VR-12 as the principal outcome measure of the Medicare 
Health Outcomes Survey (HOS).329
Research examining the VR-36 and SF-36 in such uses does inform the 
selection of PROs for performance measurement. Nevertheless, limitations 
remain to use of these measures as indicators of high-quality care and as 
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sources of information for holding practices, providers, hospitals, health plans, 
or others accountable for their results. These limitations include the “static” 
nature of these measures, meaning that for analysts to be able to obtain an 
individual’s score, all items must be administered—even those items that add 
little to the precision of measurement. In addition, content is fixed by the 
composition of the scale. Therefore, attention has turned to alternative PRO 
tools and “dynamic” instruments with clear potential for these types of uses 
(i.e., as patient-reported performance measures).
PROMIS constitutes arguably the best example of a future direction of 
PROs that will be acceptable for use in practice, quality improvement, or 
performance measurement programs. Developed using IRT methodology, 
PROMIS offers a new generation of PROMs with better reliability, validity, 
precision, and other attributes than is typically true for so-called legacy 
instruments. These measures have the important attribute of being shorter than 
such older instruments as well.187 PROMIS measures form a hybrid between 
static generic PROMs and more flexible adaptive measures. They comprise 
items that are specific to the overall content of the measure but that are also 
applicable across the diverse spectrum of health status. 
Although a growing body of literature provides preliminary evidence 
supporting the psychometric quality of the PROMIS measures, future work 
needs to explore applying PROMIS measures as tools for assessing the 
performance of health care organizations. Nevertheless, the PROMIS system 
provides a robust model by which the use of PROMs as performance measures 
can be expanded and elaborated upon, owing to its rigorous methodological 
characteristics. 
Documentation of Particular Attributes of PROMs
Documentation, in peer-reviewed literature or on publicly accessible websites 
(or both), of the evidence of a PROM to reflect all of these measurement 
properties will improve acceptance of the PROM for use as a performance 
measure. To the extent that the evidence came from populations similar 
to the studies’ target populations, the more confidence clinicians, analysts, 
administrators, and policy makers can have in the PROM to capture patients’ 
experiences and perspectives.
Applying any set of selection standards for PROs calls for attention to 
several considerations. One key issue is that the populations involved in these 
efforts will likely be quite heterogeneous. This population heterogeneity should 
be reflected in the people selected to participate in the various pilot tests or 
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studies that are part of the evaluation of the measurement properties for the 
PROM. For example, both qualitative and quantitative studies may require 
quota sampling based on race and ethnicity that reflects the prevalence of the 
condition in the study target population. Additionally, patients must be actively 
engaged as stakeholders in identifying the domains most important to measure 
and in selecting specific PROMs for use in performance measurement. 
Participants’ literacy is another important consideration for use of PROMs. 
Data collected from PROMs are valid only if the participants in a study can 
understand what is asked of them and can provide a response that accurately 
reflects their experiences or perspectives. Developers of PROMs must ensure 
that the questions and response options are clear and easy to understand. 
Pretesting of the instrument (e.g., cognitive testing) should include individuals 
with low literacy to evaluate the questions.330
Response burden must be considered when selecting a PROM. The 
instrument must not be overly burdensome for patients, as they are often sick 
and cannot be expected to tolerate completing lengthy questionnaires. 
Finally, researchers must carefully consider the strength of evidence for the 
measurement properties. No threshold exists to indicate that an instrument is 
(or is not) valid for any or all populations or applications. In addition, no single 
study can confirm all the measurement properties for all contexts. Like any 
scientific discipline, measurement science relies on an iterative, accumulating 
body of evidence examining key properties in different contexts. Thus, it is the 
weight of the evidence that informs the evaluation of the appropriateness of a 
PROM. More established PROMs will have the benefit of having accrued more 
evidence than more recent entries; however, more recent entries tend to have 
improved measurement properties that warrant attention. 
PROM Characteristics for Consideration
Generic Versus Condition-Specific Measures
One factor to consider when selecting a patient-level PROM is whether to use 
a generic instrument or a condition-specific instrument. Several considerations 
can inform this choice.331 First, the specific population of interest may guide 
whether one opts to use a generic or condition-specific PRO. For example, if 
the target population comprises mainly healthy individuals, or people with 
multiple comorbidities, a generic measure is the preferred choice. Conversely, 
if the goal is to examine a specific subset of patients with a particular diagnosis 
46  Patient-Reported Outcomes in Performance Measurement
or receiving a common treatment, then a condition-specific measure may be 
more appropriate, but this is ideally evaluated in context. 
In addition, outcomes of interest may guide the selection process. Generic 
measures may capture a different category of outcomes when compared with a 
condition-specific PROM. For example, a generic measure may assess domains 
of general function, well-being, or quality of life, whereas a condition-specific 
PRO may measure symptoms expected to be directly addressed by a condition-
specific intervention. The more focused the interest in a specific symptom or 
set of symptoms that are unique to the condition, the more likely a condition-
specific instrument will be preferred.332 
Generic PROMs have some important advantages. They allow for 
comparability across patients and populations,331 although they are more 
suitable for comparison across groups than for individual use.333 Global 
PROMs also allow assessments in terms of normative data that can be used 
to interpret scores.331 This enables evaluation against population norms or 
comparison with information about various disease conditions. They can also 
be applied to individuals without specific health conditions, and they can 
differentiate groups on indexes of overall health and well-being.331 
Generic PROMs also have some disadvantages. They may tend to be 
less responsive than condition-specific measures to focal changes that are 
better detected with a condition-specific measure. For that reason, they may 
underestimate health changes in specific patient populations.334 Additionally, 
they may fail to capture important condition-specific concerns.334 
Condition-specific PROMs are an alternative to generic PROMs. One 
advantage of condition-specific PROMs is the possibility for improved 
relevance and responsiveness.331 They also enable differentiation of groups at 
the level of specific symptoms or patient concerns.331 However, the condition-
specific focus introduces the notable difficulty of making comparisons across 
patient populations with different diseases or health conditions.331
Given their respective benefits and limitations, we recommend that a 
combination of generic and condition-specific measures is likely to be the 
best choice for the performance measurement purposes that those assessing 
or reporting on quality of care in this country, such as the NQF, have most 
in mind. Generic and condition-specific PROMs may measure different 
aspects of HRQL when administered in combination,335 resulting in more 
comprehensive assessment. Consequently, hybrid measurement systems have 
emerged to facilitate combining them. For example, the FACIT system consists 
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of a generic HRQL measure plus condition-specific subscales. PROMIS, which 
was developed to create item banks that are appropriate for use across common 
chronic disease conditions,336 represents another example of a hybrid system of 
PROMs that combines both global and targeted approaches. 
Measurement Precision
Another factor to consider when selecting a patient-level PROM is 
measurement precision. Measurement precision refers to the level of variation 
in multiple measurements of the same factor; measures with greater precision 
vary less across assessment time points. PROMs with greater measurement 
precision also demonstrate greater sensitivity to change.337 Given that most 
PROMs were originally developed as research tools, they may lack the level 
of precision necessary for assessing individuals on these types of outcomes.338 
Although performance measures will aggregate to practice, provider, or 
organization levels, adequate measurement precision at the patient level is still 
needed. 
Regarding measurement precision, measures based on IRT tend to have 
greater precision than measures based on classical test theory.338 Specifically, 
computerized adaptive tests (CATs) offer greater precision than static short-
forms derived from item banks; however, short forms are an acceptable 
alternative when CAT approaches are infeasible.339,340 Although CATs include 
a greater number of items in an item bank, they allow tailored measurement, 
resulting in shorter instruments and better precision. Consequently, using 
PROMs derived from IRT techniques is recommended to achieve the greatest 
measurement precision.
Sensitivity to Change, or Responsiveness
Sensitivity to change (also referred to as responsiveness) is another important 
factor to consider when selecting a PROM because the ability to detect a 
small, but important, change is necessary when monitoring patients and 
implementing clinical interventions.38 Sensitivity to change is a type of 
validity characterized by within-subject changes over time following an 
intervention.341,342 
Responsiveness is conceptualized in many ways, which leads to different 
findings and interpretations.343 Definitions of sensitivity to change range from 
the ability to detect any kind of change, regardless of meaningfulness (e.g., 
a statistically significant change post-treatment), to the ability to detect a 
clinically important change. To be clinically useful, PROMs must demonstrate 
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sensitivity to change both when individuals improve and when they 
deteriorate.342
Methods for assessing responsiveness vary markedly as well. These 
methods differ primarily in terms of whether they are intended to demonstrate 
statistically significant changes to quantify the magnitude of change.343 The 
lack of equivalence across methods for detecting change can be problematic for 
interpretation, given that the different methods for detecting responsiveness 
produce different classifications of who is improved or not.344 Indeed, relying 
solely on statistical tests of responsiveness is not recommended, given that 
such findings may not accurately reflect what is meaningful to patients or 
clinicians.345
Several factors can limit responsiveness to change. First, multi-trait scales 
containing items that are not relevant to the population being assessed may 
fail to capture change over time.346 The responsiveness of a PROM may also be 
constrained by using scales that offer categorical or a limited range of response 
options.346 PROMs that specify an extensive timeframe for reporting also will 
not be likely to demonstrate change, particularly when administered regularly 
over a brief period of time.346 The responsiveness of a PROM is also limited 
when it includes items that reflect stable characteristics that are unlikely 
to change. Scales that contain items with floor or ceiling effects are also 
problematic.346 A PROM sensitivity to change may depend upon the direction 
of the change. For example, Eurich and colleagues found that PROMs were 
more responsive to change when patients got better clinically than when they 
got worse.38
In addition to these factors, a growing body of research suggests that 
condition-specific PROMs can be more sensitive to change than generic 
PROMs.38,40,347–349 Responsiveness to change is likely influenced by the purpose 
for which the measure was originally developed.349 For example, measures 
developed to emphasize specific content areas would be expected to show 
greater post-treatment change in those content areas.342 The greater sensitivity 
to change in condition-specific PROMs may be attributed to the strong 
content validity inherent in condition-specific measures.38 As a result, using 
a combination of condition-specific and generic PROM may yield the most 
meaningful data.38,40
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Minimally Important Differences 
The difference between clinical versus statistical significance also merits 
consideration when selecting a PROM. Historically, research has relied upon 
tests of statistical significance to examine differences in scores between patients 
or within patients over time. However, concerns arise regarding whether 
statistically significant differences truly reflect differences that would be 
perceived as important to the patient or the clinician. Consequently, attention 
has shifted to the concept of clinically significant differences in PROM scores. 
Experts have proposed a variety of approaches to determining clinical 
significance. For example, clinically significant change has been defined as 
“changes in patient functioning that are meaningful for individuals who 
undergo psychosocial or medical interventions.”350 Similarly, meaningful 
change is defined (from the patient perspective) as “one that results in a 
meaningful reduction in symptoms or improvement in function . . . .”351 
Minimally important differences (MIDs) represent a specific approach to 
clinical significance. They are defined as “the smallest difference in score in 
the outcome of interest that informed patients or informed proxies perceive as 
important.”352 Minimum clinically important differences (MCIDs) constitute 
an even more specific category of MID. MCIDs are defined as “the smallest 
difference in score in the domain of interest which patients perceive as 
beneficial and which would mandate, in the absence of troublesome side effects 
and excessive cost, a change in the patient’s management.”353
Examining clinically significant differences poses several important 
implications.352 First, investigating clinically significant (versus statistically 
significant) differences in scores aids users in interpreting PROMs. Second, 
focusing on clinically significant differences also emphasizes the importance of 
the patient perspective, which may not be adequately captured when looking 
mainly at statistically significant differences. Third, the ability to look at 
clinically significant differences in scores informs the evaluation of the success 
of a clinical intervention. Finally, in the context of clinical research, clinically 
significant differences can assist with sample size estimation. 
Currently, no methodological gold standard exists for estimating MIDs.351,354 
Two primary methods are currently in use: the anchor-based method and the 
distribution-based method. 
The anchor-based method of establishing MIDs assesses the relationship 
between scores on the PROM and some independent measure that is 
interpretable.352 Evaluators have several options for the type of anchor they 
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might select when using an anchor-based method. For instance, clinical 
anchors that are correlated with the PROM at the r ≥ 0.30 level may serve as 
appropriate anchors.304,317 Clinical trial experience can inform the selection of 
these clinical anchors,355 including the use of multiple clinical anchors.356 
Transition ratings represent another potential source of anchors when 
establishing MIDs. Transition ratings are patients’ within-person ratings of 
change.317,357 However, because of concerns about validity, experts recommend 
that researchers or other users examine the correlation between pre- and post-
test scores and the transition rating.358 Patients’ between-person differences can 
also be used as anchors when establishing MIDs for PROMs.314,317 Additional 
sources for anchors when establishing MIDs include HRQL-related functional 
measures used by clinicians317,357 and objective standards (e.g., hospital 
admissions, time away from work).358
Although the anchor-based method offers promise for establishing MIDs 
in PROMs, several limitations should be considered. First, the transition 
rating approach to anchor selection is subject to recall bias on the part of 
the patient.351 Second, global ratings may account for only some variance in 
scores.351 Third, the anchor-based method does not take into consideration the 
measurement precision of the instruments being used.351
The distribution-based method represents the second method of 
establishing MIDs in PROMs. The distribution-based method uses the 
statistical characteristics of the scores when establishing MIDs.352 Specifically, 
the distribution-based approach evaluates change in scores in relation to the 
probability that the change occurred at random.351 
As in the case of the anchor-based method, several methods are available 
when applying a distribution-based approach to establishing MIDs. First, 
the t-test statistic has been used to establish MIDs when examining change 
over time.351 However, given that this relies solely on statistical significance, 
it may not reflect change that is clinically meaningful, and it is also subject 
to variation due to sample size.351 Second, distribution-based methods may 
also be grounded in measurement precision and the standard error of the 
mean (SEM).351 Specifically, the 1 SEM criterion can be used as an alternative 
to MID when assessing the magnitude of PROM score changes.359 Sample 
variation, such as effect size and standardized response mean, constitutes 
another method for establishing MIDs using the distribution-based method.351 
When using this method, it is recommended that the effect size be specific to 
the population being studied.357 Evidence suggests that MID estimates using 
sample variation are approximately one-half of a standard deviation.360 
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Finally, reliable change constitutes another method of using the 
distribution-based approach to establish MIDs.351 Reliable change is based 
on the standard error of measurement difference (SEMD); it indicates how 
much the observed change in an imprecise measure exceeds fluctuations that 
are random in nature.351 Although the distribution-based approach serves as a 
possible alternative to the anchor-based methods, little consensus exists on the 
benchmarks for establishing changes that are clinically significant.351
Given limitations of the anchor- and distribution-based approaches, experts 
recommend that users apply multiple methods and triangulation to determine 
the MID.304,351,360 Moreover, the final selection of MID values should be based 
on systematic review and an evaluation process such as the Delphi method.304 
MID values should also be informed by a stakeholder consensus, which 
includes patient engagement and input, about the extent of change considered 
to be meaningful. For example, in some cases, the desired outcome may be 
scores over time, such as in the case of interventions designed to preserve and 
prevent declines in functioning. Consequently, the specific application of the 
PRO will inform the MID values, particularly when considering the contrasts 
between interventions for acute clinical conditions and interventions or 
support for long-term or chronic conditions. 
When considering MIDs for PROMs, evaluators should not apply a 
single MID to all situations. MIDs may vary by population and by context.304 
Consequently, those reporting such data should provide a range around the 
MID, rather than just a single MID value.356 Finally, because the criteria for 
assessing clinically important change in individuals do not directly translate 
to evaluating clinically important group differences,317 a useful strategy is to 
calculate the proportion of patients who experience a clinically significant 
change.280,317
Essential Conditions to Integrate PROMs Into the 
Electronic Health Record
General Considerations for Health Information Technology 
Health information technology (HIT) has the potential to enable dramatic 
transformation in health care delivery. To date, however, the empirical research 
evidence base supporting its benefits is limited.361
E-health refers to health-related Internet applications that deliver a range 
of content, connectivity, and clinical care.11 This includes health information, 
online formularies, prescription refills, appointment scheduling, test results, 
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advance care planning and health care proxy designation, and physician-
patient communication.362 Patient-centered e-health (PCEH) is an emerging 
discipline that is defined as the combination of three themes:363
• Patient focus: PCEH applications are developed primarily based on needs 
and perspectives of patients.
• Patient activity: PCEH application designs assume that patients can 
participate meaningfully in providing and consuming information about, 
and of interest to, them.
• Patient empowerment: PCEH applications assume that patients want 
to, and are able to, control far-ranging aspects of their health care via a 
PCEH application. 
Although e-health applications have become common, they tend to focus 
on the needs of health care providers and organizations. Patients desire a range 
of services to be brought online by their own health care providers.364 However, 
little evidence is available as to whether the services offered by providers are 
services that patients desire.12 One important consideration is that providers 
attend to patient acceptability factors.12,365
Measuring PROMs will constitute an important aspect of future stages 
of “meaningful use” of electronic health records (EHRs).366,367 Access can be 
enhanced by allowing entry directly from commonly used devices such as 
smartphones. Enabling clinical decision support by providing structured data 
directly into EHRs will permit PROMs to be used for (1) tracking patient 
progress over time or (2) through individual question responses, driving 
change in care plans or care processes concurrently, thus improving outcomes 
over time. The use of a standardized instrument registered in an established 
code system (e.g., LOINC [Logical Observation Identifier Names and Codes]) 
enables EHRs to incorporate the instrument as an observation with a known 
set of responses using standard terminology (SNOMED-CT [Systematized 
Nomenclature of Medicine—Clinical Terms]) or numerical responses. Each 
question in the standardized instrument can also be coded (structured) 
to drive changes based on those responses. Unfortunately, in an updated 
systematic review of HIT studies published between 2004 and 2007, PROMs 
were not mentioned at all.362
The passage of the Health Information Technology for Economic and 
Clinical Health (HITECH) Act creates a mix of incentives and penalties that 
will induce a large proportion of physicians and hospitals to move toward 
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EHR systems by the end of the 2010s.368 The discussion should now focus on 
whether HIT will support the models of care delivery that will help achieve 
broader policy goals: safer, more effective, and more efficient care.
Three features of EHRs are critical to enable accountable care organizations 
to succeed: interoperability and widespread health information exchange; 
automated, real-time quality and cost measurement; and smarter analytic 
capacities. Having a complete picture of the patient’s care is a critical start, yet 
most EHRs are not interoperable and have limited data-sharing capabilities.369 
In summary, important issues include (1) the patient perspective (patients 
want to be involved “as a participant and partner in the flow of information” 
relating to their own health care);370 (2) clinical buy-in; (3) compatibility with 
clinical flow; and (4) meaningful use.
Examples of PROMs in Electronic Health Record Applications
Health care centers are beginning to implement ways to use patient-reported 
information (the voice of the patient) to provide higher quality care.371 
Three recent case studies (two in the United States and one in Sweden) are 
particularly informative, because they illustrate lessons learned about such 
initiatives.371 
The Dartmouth Spine Center collects health survey data from patients 
before each visit, either at home or in the clinic. Analysts summarize the data 
in a report and make it available for use by patients and clinicians to develop 
or modify care plans and to monitor results over time to guide treatment 
decisions. Longitudinal changes are incorporated into the report with each 
new assessment. At Group Health Cooperative in the State of Washington, an 
electronic health risk assessment has been integrated with the EHR. Patients 
can complete PROMs, make appointments, fill prescriptions, review health 
benefits, communicate with their providers, and get vetted health information. 
Customized reports are available to patients and providers. The Karolinska 
University Hospital in Stockholm, Sweden, developed a Swedish Rheumatology 
Quality registry in 1995 to improve the quality and value of care for people 
suffering from arthritis and other rheumatic diseases. Beginning in 2003, 
its web-based system replaced paper forms. The system uses real-time data 
provided by patients, clinicians, and diagnostic tests. Longitudinal summaries 
of PROMs and other health information are incorporated into graphical 
reports that are available to patients and providers. 
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Both patients and clinicians have generally favorable reactions to the 
patient-reported measurement systems implemented in these three very 
different health care settings. The information gathered helps to support 
patient-centered care by focusing attention on the health issues and outcomes 
that are important to patients. Although both patients and clinicians 
acknowledge that using PROMs takes extra time for data collection, both 
groups report that it makes the care more effective and efficient. Key design 
principles to successful use of patient-reported measurement systems include 
fitting PROMs into the flow of care, designing the systems with stakeholder 
engagement, merging data with other types of data (clinician reports, medical 
records, claims), and engaging in continuous improvement of the systems 
based on users’ experiences and new technology.
Other examples include use of PROMs in managing advanced cancer 
where the primary goals of care are to maximize symptom management and 
minimize treatment toxicity. Clinicians and patients often base treatment 
decisions on informal assessments of HRQL. Integrating formal HRQL 
assessment into treatment decision making can improve patient-centered care 
for cancer patients with advanced disease. Computer-based assessment can 
reduce patient and administrative burden while enabling real-time scoring and 
presentation of HRQL data. Two pilot studies conducted with patients with 
advanced lung cancer reported that the computer technology was acceptable 
and feasible for patients and physicians.167,372 Patients felt that the HRQL 
questionnaire helped them focus on issues to discuss with their physicians, and 
physicians indicated that the HRQL report helped them to evaluate patient 
responses over time.
A new initiative in the Robert H. Lurie Comprehensive Cancer Center 
at Northwestern University involves developing and implementing patient-
reported symptom assessment in gynecologic oncology clinics. Before their 
clinic visits, outpatients complete instruments measuring fatigue, pain, physical 
function, depression, and anxiety through the EHR patient communication 
portal at home or in the clinic using an iPad. Results immediately populate 
the EHR. Severe symptoms trigger EHR notifications to providers. The EHR 
also provides automated triage for psychosocial and nutritional care when 
indicated.
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Selection of PROMs That Meet Recommended Characteristics for Use 
in Performance Measures
Throughout this monograph, we have recommended several criteria that 
researchers and evaluators can use when assessing the appropriateness of a 
PROM for measuring quality of care and performance; Table 4 summarized 
critical points. Given that PROMs are not yet in widespread use in clinical 
practice, little is known about how best to aggregate these patient-level 
outcomes for measuring the quality of care or performance of the health care 
entity. Despite this limitation, accommodating the needs of patients with 
diverse linguistic, cultural, educational, and functional skills calls for evidence 
about the equivalence of multiple methods and modes of questionnaire 
administration. Additionally, scoring, analyzing, and reporting PRO response 
data all need to be user-friendly and understandable to clinicians for real-time 
use in clinical settings. Moreover, the timing of measurement must include 
administration before therapeutic interventions to allow for measuring 
responsiveness to change, doing risk adjustment, and screening patients for 
clinical intervention
To illustrate the application of these recommended characteristics when 
evaluating the appropriateness of a PROM for these purposes, Table 4 
included one illustration of these points related to determining the success 
of total hip arthroplasty. Total hip arthroplasty has emerged as an acceptable 
surgical treatment for individuals experiencing intractable pain and severe 
functional impairments for whom conservative treatment has yielded minimal 
improvement.373–376 The most common indication for total hip arthroplasty is 
joint deterioration secondary to osteoarthritis.377 Consequently, the aging of the 
population is likely to raise demand for both primary total hip arthroplasty and 
revision procedures.378–380 
PROs have increasingly been included alongside more traditional indices 
of surgical outcome such as morbidity and mortality when evaluating the 
success of total hip arthroplasty. With the expanding focus on patient-
reported outcomes, such as functioning and quality of life, numerous, 
diverse PROMs have been developed and applied in measuring total hip 
arthroplasty outcomes.377 Thus, this intervention provides a relevant context 
in which to review the use of recommended characteristics in the selection 
of PROMs, specifically with the characteristics of the WOMAC, a PROM 
developed to examine pain, stiffness, and physical function in individuals with 
osteoarthritis.307 
Conclusions
PRO measures have reached a level of sophistication that enables wider 
use in assessing performance in clinical settings. Attention to the many 
methodological considerations discussed in this monograph will help users 
to produce meaningful, actionable results. Judicious use of a mixture of 
generic and condition-specific assessment instruments, acceptance of modern 
measurement methods such as IRT, and application of technology to enable 
standardized, equitable assessment across a range of patients are essential in 
this process. Implementing contemporary options, such as those offered by 
the PROMIS instruments, can effectively shorten assessment time without 
compromising accuracy. These attributes facilitate meeting the demands of 
clinical application of PROs for performance measurement.
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